President Trump on Friday announced new agreements with nine pharmaceutical manufacturers aimed at reducing certain prescription drug prices.
Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...
The Trump administration has talked tough about cutting drug prices, but the impacts of the deals with drug companies ...
Senior administration officials say pharmaceutical companies are now rushing to ink deals of their own with the president.
Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...
The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President ...
The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.
The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s “most ...
Eli Lilly stock hits a 90+ Quality score. BofA calls LLY underpriced, citing major growth ahead for its oral obesity drug.
The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results